19 june 2018 daily equity report

1. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 13THJUNE 2018 Daily Equity Report Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. INDIAN FACE ! INDIAN EQUITY BENCHMARK:- Benchmark indices BSE INDIAN MARKET CLOSE PREVIOUS Sensex and NSE’s Nifty 50 closed higher on Tuesday amid mixed sentiment from global equity markets. US-North Korea ASIAN MARKET summit began in Singapore. Moreover, investors were also CLOSE PREVIOUS cautious ahead of key retail inflation data due to be released after 5.30pm. IIP will be at 6% for April from 4.4% a month NIKKEI ago. CPI maycome at 4.90% for May versus 4.58% last month. BSE Sensex closed higher by 209.05 points, or 0.59%, to 2468.55 35,692.52, while the Nifty 50 rose 55.90 points, or SECTORIAL INDICES 0.52%, to close at 10,842.85. CLOSE CHANGE (%) ! +0.54 Oil prices rose for a second day on Tuesday and volatility subsided to its lowest in three weeks, as investors prepared for a key meeting of the OPEC producer group next week. Crude remained in a tight trading range, in line with the broader financial markets, which were largely unruffled by a U.S.-North Korea summit aimed at denuclearisation of the Korean peninsula. OPEC kingpin Saudi Arabia and Russia have indicated they would be willing to raise output to make up for any supply shortfall. GLOBAL FACE 9386.45 +0.58 5053.45 +0.93 5827.30 +0.58 +0.58 CLOSE CHANGE (%) +6.38 +5.37 ! 284.00 +3.65 Asian Market - Asian markets finished higher today with shares in China leading the region. The Shanghai Composite is up 0.89% while Japan's Nikkei 225 is up 0.33% and Hong Kong's Hang Seng is up 0.13%. INDUSIND +2.53 TOP LOSERS ! CLOSE CHANGE (%) U.S. Market - The Dow Jones Industrial Average rose 5.78 points, or 0.02 percent, to 25,322.31, the S&P 500 gained 2.97 points, or 0.11 percent, to 2,782 and the Nasdaq Composite added 14.41 points, or 0.19 percent, to 7,659.93. -2.15 -1.63 -1.54 ! -1.50 European markets - European markets are mixed. The DAX is higher by 0.06%, while the FTSE 100 is leading the CAC 40 lower. They are down 0.27% and 0.18% respectively. Daily Equity Report Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. NIFTY SPOT CHANGE (%) 19.97 STRATEGY SCRIPT CLOSE BGRENERGY PIVOT POINTS P 10825 MMTC 13.80 R1 R2 R3 10965 10686 10756 10801 10871 10895 RESISTANCE R1-10920 R2-10985 583.90 13.53 SUPPORT S1-10730 S2-10640 NIFTY HCLINFOSYS 12.24 CHANGE (%) CLOSE UNITECH 4.90 JBF INDS FII & DII ACTIVITY NET (CR.) 4017.16 BANK NIFTY FUTURE DII 4192.89 NSE TOTALS BULLISH BUY ON DIP PIVOT POINTS P 26578 ADVANCE S3 S1 R1 R2 26775 RESISTANCE R3 26972 26184 26508 26705 BANK NIFTY BANK NIFTY Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report MARKET TALKS ! Religare Finvest files suit against Lakshmi! Vilas Bank Lakshmi Vilas Bank Ltd said that Religare Finvest Ltd has filed a suit against the bank’s Janpath branch. The bank held Rs794 crore in deposits related to security for loans extended to RHC Holding Pvt. Ltd and Ranchem Pvt. Ltd. On account of default in clearing the loans, the deposits were closed and adjusted to clear the loans. Lakshmi Vilas Bank shares were flat at Rs117.50. Fortis Healthcare shares fall over 1% Fortis Healthcare Ltd shares were trading 1.46% lower at Rs141.50. The board of Fortis Healthcare has extended the date for submission of binding offers by a Finvest as are yet to be finalized. On Monday the due diligence of Fortis has unearthed unpaid vendors’ bills of Rs450 crore, a Rs503 crore penalty on its subsidiary Fortis Escorts Heart Institute and undisclosed land-related issues at three of its hospitals. the proceeds were ! patent! Suven Life approval Suven Life Sciences Ltd said that it has received one product patent from each China and US corresponding to new chemical entities for the treatment of disorders associated with neurodegenerative diseases. Shares of Suven Life Sciences rose 1.66% to Rs230.10. Stride Shasun shares gain over 4% on USFDA drug approval Shares of Stride Shasun Ltd rose 4.3% to Rs365 after the company said it got USFDA approval for generic Tamiflu capsules for the US market. As per IQVIA MAT April 2018 data, the US market for Oseltamivir Phosphate Capsules was approximately $725 Million. The product will be manufactured at the company’s Oral dosage facility at Bangalore and will be marketed by Strides Pharma in the US Market. The company has 75 cumulative ANDA filings with USFDA of which 48 ANDAs have been approved as of date and 27 are pending approval. shares gain after ! Orchid Pharma shares rise 5% Shares of Orchid Pharma Ltd rose 5% to Rs7.44 after the company said it got EU good manufacturing practices certificate following the inspection of its API manufacturing facility in Tamil Nadu. The facility was inspected in November 2017. . Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. Capitalstars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars is a research house and an investment advisory company carrying out operations in the Indian Equities and commodity market. We generate intraday as well as delivery calls in Stock cash and F&O in NSE & BSE, Commodities including bullions, metals & Agro- commodities traded in MCX and NCDEX. We provide recommendations Live through SMS & Chat room services. Our SMS facility is a very effective system which ensures the instant message delivery without any loss of time, so the clients get sufficient time to execute their trades in order to fetch maximum Profits. Visit us: www.capitalstars.com Call us: 9977499927 O731-6690000 Our services: MCX TIPS, INTRADAY STOCK TIPS, FINANCIAL ADVISORY COMPANY,

7. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.